Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China
|
MSCI China Small-Cap
|
Hang Seng Index
|
Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Lab monkeys

During the Covid pandemic, lab monkeys that are one of Joinn’s main businesses were in short supply as companies rushed to develop Covid vaccines and drugs.

FAST NEWS: Joinn Laboratories spents $3.7 million on share buyback

The Latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), said on Monday that since announcing a plan on Mar. 27 to repurchase its A…
June 4, 2024
6127.HK
603127.SHG
Joinn Laboratories, China’s leading non-clinical contract research organization (CRO), announced on Tuesday it expects to report a net profit of 311 million to 419 million yuan for 2023, down 61.1% to 71.1% from the previous year.

FAST NEWS: Joinn Lab profit plunges, sending shares to 52-week low

The latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), announced on Tuesday it expects to report a net profit of 311 million ($43.8…
January 24, 2024
6127.HK
603127.SHG
Joinn Laboratories, China’s leading non-clinical contract research organization (CRO), announced on Monday its revenue rose 15.1% to 575 million yuan in the third quarter.

FAST NEWS: Joinn Lab profit slumps on falling lab monkey prices

The latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), announced on Monday its revenue rose 15.1% to 575 million yuan ($78.6 million) in the third quarter,…
October 31, 2023
6127.HK
603127.SHG

Joinn profits slide as lab monkey build-up backfires

The leading provider of pre-clinical drug research has predicted its first-half profits will plummet between 70% and 80% due to the falling value of its lab animals Key Takeaways: Joinn…
July 21, 2023
6127.HK
603127.SHG

Recent Articles

During the Covid pandemic, lab monkeys that are one of Joinn’s main businesses were in short supply as companies rushed to develop Covid vaccines and drugs.
June 4, 2024

FAST NEWS: Joinn Laboratories spents $3.7 million on share buyback

6127.HK
603127.SHG
January 24, 2024

FAST NEWS: Joinn Lab profit plunges, sending shares to 52-week low

6127.HK
603127.SHG
October 31, 2023

FAST NEWS: Joinn Lab profit slumps on falling lab monkey prices

6127.HK
603127.SHG
July 21, 2023

Joinn profits slide as lab monkey build-up backfires

6127.HK
603127.SHG

RELATED ARTICLES

No related posts.

Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.